Secretary of stem cells sciences and technologies development headquarter stated: to facilitate the entrance of gene therapy products into the market, we need to define the infrastructures and design relevant regulations. In this regard, following up the gene therapy regulations has been prioritized in the mentioned headquarter.

According to the public relations and information center of the Vice-Presidency for science and technology affairs, Amir Ali Hamidieh, secretary of the stem cells sciences and technologies development headquarter, expressed about the necessity of providing the necessary infrastructures for commercialization of gene therapy products, asserting: now is the time to turn knowledge into technology. To facilitate the entrance of gene therapy products into the market, we need to define the infrastructures and design relevant regulations. In this regard, following up the gene therapy regulations has been prioritized in the mentioned headquarter.

He continued: hemophilic rat production by scientists at the National Institute of Genetic Engineering and Biotechnology shows the bright future of the technology in this field. Although specialists have knowledge of product production, experts must be available in the field of business knowledge to facilitate the entrance of products into the market.

Hamidieh also marked: given the capacity of the regional market, the potential for presenting products in the international markets must be considered in the economic model for these products.